MedTrace Logo

Comparions the Effect of Different Treatment Modalities on Chronic Plantar Fasiitis

NCT04323319 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 63

Last updated 2020-03-26

No results posted yet for this study

Summary

Plantar fasciitis is a common cause of heel pain affecting about 20% of the general population. The basic treatment of plantar fasciitis is conservative. Approximately 85-90% of plantar fasciitis patients can be successfully treated without surgery. Methods include resting, nonsteroidal anti-inflammatory drugs, stretching, shoe orthotics, corticosteroid injections, physical therapy, night splints, and extracorporeal shock wave therapy (ESWT) and ultrasound therapy. Plantar fasciitis treatment is a chronic treatment that has been clearly described in the literature despite the use of treatment modalities. In the literature, treatment modalities which should be used respectively in the treatment of plantar fasciitis are expressed. Nevertheless, it is a chronic disease caused by skipping the treatment steps for various reasons or applying the treatments in the wrong hierarchy. The aim of this project is to compare the effects of stretching exercises, ESWT and instrument-assisted myofascial relaxation technique (Graston Technique®) in the treatment of chronic plantar fasciitis in terms of pain, disability level, quality of life and static and dynamic plantar pressure analysis.

Conditions

  • Plantar Fasciitis, Chronic

Interventions

DEVICE

ESWT, Graston Technique

The treatment period for each group was determined as 4 weeks. Stretching program for each group will be given as home exercise program. Stretching exercises will be completed in 3 sets, 2 sets per day, stretching for 30 seconds. Graston Technique Group will take treatment 2 times per week, ESWT group will take treatment 1 time per week.

Sponsors & Collaborators

  • Bahçeşehir University

    lead OTHER

Principal Investigators

  • Pelin Pişirici, PT, PhD · Medipol University Institute of Health Sciences

  • Dilber Karagozoglu Coskunsu, PT, PhD · Bahçeşehir University Faculty of Health Sciences

  • Feryal Subaşı, PT, Prof · Yeditepe University Faculty of Health Sciences

  • Uğur Şaylı, MD. Prof. · Yeditepe University Hospital

  • Elif Tugce Cil, PT, MSc · Yeditepe University Faculty of Health Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-12-27
Primary Completion
2020-01-30
Completion
2020-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04323319 on ClinicalTrials.gov